Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

HOLLYWOOD, FLA. – The benefits of short-term trial immunosuppressive therapy outweigh the risks in inflammatory bowel disease, but certain patient populations require more vigilance than others, Dr....